Morning Market Losers

shares declined 14.57% to $98.05. Pacira Pharma received a complete response letter from the FDA for sNDA seeking approval of EXPAREL.

shares fell 12.60% to $5.34. BioScript reported a Q4 loss of $0.90 per share on revenue of $253.7 million.

shares slipped 12.01% to $18.83. Compass Point downgraded Navient from Buy to Neutral and lowered the price target from $23.00 to $22.00.

shares dropped 9.80% to $8.10 after the company issued an update on 2015 exploration drilling program.

shares fell 8.48% to $4.10 after the company priced the public offering of common stock.

shares declined 5.09% to $8.76 after the company provided additional information on temporary suspension of sales by provincial sports lottery administration centers.

shares dropped 2.92% to $66.56. Isis Pharmaceuticals reported that it has earned a $15 million milestone payment from GSK related for advancing ISIS-TTRRx. Stifel Nicolaus downgraded Isis Pharmaceuticals from Buy to Hold and removed the price target of $66.00.

shares declined 2.45% to $40.95 after falling 6.00% on Friday.